Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 8, 2024Frontiers in PharmacologyOpen Access

Isorhamnetin: what is the in vitro evidence for its antitumor potential and beyond?

View Full Paper
Ask AI
Bookmark
Share

Authors

JLJiaming LeiJYJianbao YangCBCuiyu Bao

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lei et al. (2024) studied this question.

synapsesocial.com/papers/68e6fec0b6db64358767960ahttps://doi.org/10.3389/fphar.2024.1309178
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries2021 · 114,748 citations
  2. 2Health promoting properties and sensory characteristics of phytochemicals in berries and leaves of sea buckthorn (<i>Hippophaë rhamnoides</i>)2021 · 72 citations
  3. 3Adipose tissue mitochondrial dysfunction triggers a lipodystrophic syndrome with insulin resistance, hepatosteatosis, and cardiovascular complications2014 · 178 citations
  4. 4The effects of <i>Ginkgo biloba</i> on metabolic syndrome: A review2020 · 109 citations
  5. 5Isorhamnetin Suppresses Skin Cancer through Direct Inhibition of MEK1 and PI3-K2011 · 109 citations